Furanopyrimidines

The present invention relates to furanopyrimidine compounds having the general Formula I: and stereoisomers, tautomers, solvates, pharmaceutically acceptable salts and derivatives, and prodrugs thereof. The invention also includes pharmaceutical compositions comprising a compound of Formula I, metho...

Full description

Saved in:
Bibliographic Details
Main Authors BURKITT SIMON A, MARSHALL TERESA L, DIMAURO ERIN F, ZHU XIAOTIAN, FRENKEL ALEXANDER D, LIU JINQIAN, MCGOWAN DAVID C, HARRISON MARTIN J, BUCHANAN JOHN LAIRD, BUCKNER WILLIAM H, FARTHING CHRISTOPHER N, LIVELY SARAH E, KAYSER FRANK, SHARMA RAJIV, SHUTTLEWORTH STEPHEN J
Format Patent
LanguageEnglish
Published 17.08.2010
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to furanopyrimidine compounds having the general Formula I: and stereoisomers, tautomers, solvates, pharmaceutically acceptable salts and derivatives, and prodrugs thereof. The invention also includes pharmaceutical compositions comprising a compound of Formula I, methods of treating various diseases and conditions in a mammal, including inflammation, inhibition of T cell activation, proliferation, arthritis, organ transplant, ischemic or reperfusion injury, myocardial infarction, stroke, multiple sclerosis, inflammatory bowel disease, Crohn's disease, lupus, hypersensitivity, type 1 diabetes, psoriasis, dermatitis, Hashimoto's thyroiditis, Sjogren's syndrome, autoimmune hyperthyroidism, Addison's disease, autoimmune diseases, glomerulonephritis, allergic diseases, asthma, hayfever, eczema, cancer, colon carcinoma and thymoma, comprising administering to the mammal a therapeutically effective amount of a compound of Formula I. The invention also relates to methods of manufacturing medicaments, which comprise one or more compounds of Formula I.
Bibliography:Application Number: US20050169312